(Circulation. 1999;100:675-683.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
From the Rammelkamp Center for Education and Research (Y.A.K., G.M.B., P.K., C.-C.S., A.M.B.), MetroHealth Campus, and the Departments of Physiology and Biophysics (Y.A.K., A.M.B.), Medicine (G.M.G.), and Pathology (H.F.), Case Western Reserve University, Cleveland, Ohio, and Centocor Inc., Molvern, Pa. (S.A.C.).
Correspondence to Arthur Brown, MD, PhD, Rammelkamp Center R301, 2500 MetroHealth Drive, Cleveland, OH 44109-1998. E-mail abrown{at}research.mhmc.org
BackgroundPatients with chronic iron overload may develop a cardiomyopathy manifested by ventricular arrhythmias and heart failure. We hypothesized that iron-loaded cardiomyocytes may have abnormal excitability.
Methods and ResultsWe examined a new model of human iron overload, the Mongolian gerbil given repeated injections of iron dextran. In ventricular myocytes, we measured iron concentration and distribution, action potential, sodium and potassium currents, and sodium channel protein. We showed for the first time that (1) the iron content of gerbil ventricular cardiomyocytes was increased to amounts similar to those of patients with iron-induced cardiomyopathy; (2) the overshoot and duration of the cardiac action potential decreased; (3) sodium current was reduced, steady-state inactivation was enhanced, and single-channel currents were unchanged; and (4) transient outward potassium current was increased, but inwardly rectifying potassium current was unchanged. Neonatal rat cardiomyocytes incubated with iron for 1 to 3 days showed similar changes, and levels of cardiac sodium channel proteins were unchanged.
ConclusionsAbnormal excitability and heterogeneous cardiac iron deposition may cause the arrhythmogenesis of human siderotic heart disease.
Key Words: iron overload cardiomyopathy gerbil sodium channels potassium channels
This article has been cited by other articles:
![]() |
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation Physiol Rev, April 1, 2007; 87(2): 425 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Wood, M. Otto-Duessel, M. Aguilar, H. Nick, M. D. Nelson, T. D. Coates, H. Pollack, and R. Moats Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy Circulation, July 26, 2005; 112(4): 535 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. J. Wang, L. Lian, Q. Chen, H. Zhao, T. Asakura, and A. R. Cohen 1/T2 and Magnetic Susceptibility Measurements in a Gerbil Cardiac Iron Overload Model Radiology, March 1, 2005; 234(3): 749 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Schwartz, Z. Li, D. E. Schwartz, T. G. Cooper, and W. E. Braselton Earliest cardiac toxicity induced by iron overload selectively inhibits electrical conduction J Appl Physiol, August 1, 2002; 93(2): 746 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kletzmayr, G. Sunder-Plassmann, and W. H. Horl High dose intravenous iron: a note of caution Nephrol. Dial. Transplant., June 1, 2002; 17(6): 962 - 965. [Full Text] [PDF] |
||||
![]() |
R. Mattera, G. P. Stone, N. Bahhur, and Y. A. Kuryshev Increased Release of Arachidonic Acid and Eicosanoids in Iron-Overloaded Cardiomyocytes Circulation, May 15, 2001; 103(19): 2395 - 2401. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Antzelevitch The Brugada syndrome: diagnostic criteria and cellular mechanisms Eur. Heart J., March 1, 2001; 22(5): 356 - 363. [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |